SIGHT SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SIGHT SCIENCES, INC. (SGHT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-05-06
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 7.38K shares, a 99.46% decline from fiscal 2023.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.36M shares, a 2.06% decline from fiscal 2022.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.39M shares, a 44.16% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-04 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-08 | 0.00 shares derived: sum of 3 quarters · filed 2025-05-08 | 0.00 shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-07 | 0.00 shares derived: sum of 3 quarters · filed 2025-03-07 | 7.38K shares 10-K · filed 2025-03-07 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-07 | 7.38K shares 10-Q · filed 2024-11-07 | 612.19K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 7.38K shares 10-Q · filed 2024-08-02 | 612.19K shares derived: sum of 3 quarters · filed 2024-08-02 | 621.88K shares derived: sum of 4 quarters · filed 2024-08-02 |
| 2024-03-31 | 7.38K shares 10-Q · filed 2024-05-06 | 612.19K shares derived: sum of 2 quarters · filed 2024-05-06 | 621.88K shares derived: sum of 3 quarters · filed 2024-05-06 | 733.99K shares derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | 604.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 614.51K shares derived: sum of 2 quarters · filed 2024-03-13 | 726.61K shares derived: sum of 3 quarters · filed 2024-03-13 | 1.36M shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 9.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 121.80K shares derived: sum of 2 quarters · filed 2023-11-07 | 755.50K shares 10-Q · filed 2023-11-07 | 768.70K shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 112.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 745.80K shares 10-Q · filed 2023-08-07 | 759.00K shares derived: sum of 3 quarters · filed 2023-08-07 | 781.80K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 633.70K shares 10-Q · filed 2023-05-08 | 646.90K shares derived: sum of 2 quarters · filed 2023-05-08 | 669.70K shares derived: sum of 3 quarters · filed 2023-05-08 | 694.60K shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | 13.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 36.00K shares derived: sum of 2 quarters · filed 2023-03-16 | 60.90K shares derived: sum of 3 quarters · filed 2023-03-16 | 1.39M shares 10-K · filed 2023-03-16 |
| 2022-09-30 | 22.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 47.70K shares derived: sum of 2 quarters · filed 2022-11-10 | 1.38M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 24.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 1.35M shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 1.33M shares 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 2.49M shares 10-K · filed 2022-03-24 | |||
| 2021-06-30 | 2.34M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |